Treatment of hepatitis Delta
Heiner Wedemeyer, Svenja Hardtke, Michael P. Manns – 20 December 2013 – Watch a video presentation of this article
Speeding up hepatocyte proliferation: How triiodothyronine and β‐catenin join forces
- Read more about Speeding up hepatocyte proliferation: How triiodothyronine and β‐catenin join forces
Rolf Gebhardt – 19 December 2013
Population health impact and cost‐effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China
Mehlika Toy, Joshua A. Salomon, Hao Jiang, Honglian Gui, Hui Wang, Jiangshe Wang, Jan Hendrik Richardus, Qing Xie – 19 December 2013 – Inactive chronic hepatitis B (CHB) carriers make up the largest group of hepatitis B virus‐infected patients, and China bears the largest total CHB burden of any country. We therefore assessed the population health impact and cost‐effectiveness of a strategy of lifelong monitoring for inactive CHB and treatment of eligible patients in Shanghai, China.
Fate of abstracts presented at the 2004‐2008 International Liver Transplantation Society meetings
Patrick J. Hackett, Marina Guirguis, Nozomi Sakai, Tetsuro Sakai – 19 December 2013 – Only 20.5% to 61.6% of abstracts presented at biomedical meetings are subsequently published as full‐length articles. The aim of this study was to analyze the abstract‐to‐publication rate of International Liver Transplantation Society (ILTS) meeting abstracts. Abstracts presented at 5 consecutive annual ILTS meetings (2004‐2008) were included to ensure a minimum follow‐up period of 4 years.
Raising‐flap technique for outflow reconstruction in living donor liver transplantation
Long‐Bin Jeng, Ashok Thorat, Ping‐Chun Li, Ming‐Li Li, Horng‐Ren Yang, Chun‐Chieh Yeh, Te‐Hung Chen, Chia‐Hao Hsu, Shih‐Chao Hsu, Kin‐Shing Poon – 18 December 2013
How does met regulate the survival/apoptosis balance?
Alessandro Furlan, David Tulasne – 17 December 2013
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab‐containing chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, Ryuzo Ueda – 17 December 2013
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Paul Martin, Andrea DiMartini, Sandy Feng, Robert Brown, Michael Fallon – 13 December 2013
Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T‐cell apoptosis
Simon C. Afford, Elizabeth H. Humphreys, Danielle T. Reid, Clare L. Russell, Vanessa M. Banz, Ye Oo, Tina Vo, Craig Jenne, David H. Adams, Bertus Eksteen – 12 December 2013 – Chronic hepatitis occurs when effector lymphocytes are recruited to the liver from blood and retained in tissue to interact with target cells, such as hepatocytes or bile ducts (BDs). Vascular cell adhesion molecule 1 (VCAM‐1; CD106), a member of the immunoglobulin superfamily, supports leukocyte adhesion by binding α4β1 integrins and is critical for the recruitment of monocytes and lymphocytes during inflammation.
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
Juan L. García‐Rodríguez, Lucía Barbier‐Torres, Sara Fernández‐Álvarez, Virginia Gutiérrez‐de Juan, María J. Monte, Emina Halilbasic, Daniel Herranz, Luis Álvarez, Patricia Aspichueta, Jose J.G. Marín, Michael Trauner, Jose M. Mato, Manuel Serrano, Naiara Beraza, María Luz Martínez‐Chantar – 12 December 2013 – Sirtuin1 (SIRT1) regulates central metabolic functions such as lipogenesis, protein synthesis, gluconeogenesis, and bile acid (BA) homeostasis through deacetylation. Here we describe that SIRT1 tightly controls the regenerative response of the liver.